Apolipoprotein E polymorphism – a risk factor for metabolic syndrome
-
Anca Sima
Abstract
Background: Metabolic syndrome is closely related to several disturbances in lipid and lipoprotein metabolism. The aim of this study was to determine the association between apolipoprotein E (apoE) genotypes and the risk of metabolic syndrome and/or coronary heart disease complications.
Methods: The study included 279 subjects divided into three groups: 1) control subjects, 2) metabolic syndrome patients, and 3) obese patients with coronary heart disease. All subjects were characterized by body mass index, and plasma levels of glucose, triglycerides, cholesterol, high-density lipoprotein cholesterol (HDL-C) and low-density lipoprotein cholesterol (LDL-C). ApoE genotypes were identified by PCR-restriction fragment length polymorphism using genomic DNA.
Results: Statistical analysis of plasma parameters showed that subjects in groups 2 and 3 had higher levels of triglycerides and lower levels of HDL-C compared to group 1. The frequencies of apoE genotypes determined in this Romanian population (65% for E3/3, 19.6% for E4/3, 9.5% for E3/2, 4.1% for E2/2, 0.6% for E4/4, 1.3% for E4/2) were in agreement with those reported for other Caucasian populations. The distribution of apoE alleles indicated a higher frequency of ɛ4 in groups 2 and 3. There was a higher frequency of the apoE4/3 genotype in groups 2 and 3, which was significantly correlated with higher levels of triglycerides and lower levels of HDL-C.
Conclusions: Correlations of apoE genotypes with these markers indicate that the ɛ4 allele is an independent risk factor for metabolic syndrome.
Clin Chem Lab Med 2007;45:1149–53.
©2007 by Walter de Gruyter Berlin New York
Articles in the same Issue
- SIBioC 2007, 39th National Congress of the Italian Society of Clinical Biochemistry and Clinical Molecular Biology, Palacongressi Rimini (Italy), 2-5 October 2007
- Third “Biologie Prospective” Santorini Conference
- Application of leukocyte transcriptomes to assess systemic consequences of risk factors for cardiovascular disease
- Ghrelin variants influence development of body mass index and plasma levels of total cholesterol in dialyzed patients
- Evaluation of genetic predisposition to insulin resistance by nutrient-induced insulin output ratio (NIOR)
- Apolipoprotein A-V gene polymorphisms in subjects with metabolic syndrome
- Prothrombogenic factors and reduced antioxidative defense in children and adolescents with pre-metabolic and metabolic syndrome
- Interleukin-6 gene promoter –174G/C polymorphism and insulin resistance: a pilot study
- Apolipoprotein E polymorphism – a risk factor for metabolic syndrome
- Peripheral blood mononuclear cells (PBMCs): a possible model for studying cardiovascular biology systems
- New perspectives and strategy research biomarkers for hepatocellular carcinoma
- Reproducibility of impaired glucose tolerance (IGT) and impaired fasting glucose (IFG) classification: a systematic review
- The uncoupling protein-1 gene −3826A/G polymorphism and hypertension in Japanese subjects
- Association between the TaqIB polymorphism in the cholesteryl ester transfer protein gene locus and postprandial plasma lipoprotein levels in heterozygotes for familial hypercholesterolemia
- Histamine induces the expression of uncoupling protein 2 (UCP2) and acid-binding protein (aP2) in white adipocytes
- Biochemical and clinical correlates of hypouricemia in surgical and critically ill patients
- Reliability of oxidative stress biomarkers in hemodialysis patients: a comparative study
- The association between lipid profiles and breast cancer among Taiwanese women
- Inverse association between serum selenium concentrations and parameters of immune activation in patients with cardiac disorders
- Associations of blood levels of insulin-like growth factor (IGF)-I, IGF-II and IGF binding protein (IGFBP)-3 in schizophrenic Arab subjects
- Sources of variation and reference intervals for serum cystatin C in a healthy Japanese adult population
- Intra-individual variation in creatinine and cystatin C
- Gammopathy interference in clinical chemistry assays: mechanisms, detection and prevention
- An Italian program of External Quality Control for chromogranin A (CgA) assay: performance evaluation of CgA determination
- Automated urinalysis: first experiences and a comparison between the Iris iQ200 urine microscopy system, the Sysmex UF-100 flow cytometer and manual microscopic particle counting
- Type B natriuretic peptide stability in frozen plasma
Articles in the same Issue
- SIBioC 2007, 39th National Congress of the Italian Society of Clinical Biochemistry and Clinical Molecular Biology, Palacongressi Rimini (Italy), 2-5 October 2007
- Third “Biologie Prospective” Santorini Conference
- Application of leukocyte transcriptomes to assess systemic consequences of risk factors for cardiovascular disease
- Ghrelin variants influence development of body mass index and plasma levels of total cholesterol in dialyzed patients
- Evaluation of genetic predisposition to insulin resistance by nutrient-induced insulin output ratio (NIOR)
- Apolipoprotein A-V gene polymorphisms in subjects with metabolic syndrome
- Prothrombogenic factors and reduced antioxidative defense in children and adolescents with pre-metabolic and metabolic syndrome
- Interleukin-6 gene promoter –174G/C polymorphism and insulin resistance: a pilot study
- Apolipoprotein E polymorphism – a risk factor for metabolic syndrome
- Peripheral blood mononuclear cells (PBMCs): a possible model for studying cardiovascular biology systems
- New perspectives and strategy research biomarkers for hepatocellular carcinoma
- Reproducibility of impaired glucose tolerance (IGT) and impaired fasting glucose (IFG) classification: a systematic review
- The uncoupling protein-1 gene −3826A/G polymorphism and hypertension in Japanese subjects
- Association between the TaqIB polymorphism in the cholesteryl ester transfer protein gene locus and postprandial plasma lipoprotein levels in heterozygotes for familial hypercholesterolemia
- Histamine induces the expression of uncoupling protein 2 (UCP2) and acid-binding protein (aP2) in white adipocytes
- Biochemical and clinical correlates of hypouricemia in surgical and critically ill patients
- Reliability of oxidative stress biomarkers in hemodialysis patients: a comparative study
- The association between lipid profiles and breast cancer among Taiwanese women
- Inverse association between serum selenium concentrations and parameters of immune activation in patients with cardiac disorders
- Associations of blood levels of insulin-like growth factor (IGF)-I, IGF-II and IGF binding protein (IGFBP)-3 in schizophrenic Arab subjects
- Sources of variation and reference intervals for serum cystatin C in a healthy Japanese adult population
- Intra-individual variation in creatinine and cystatin C
- Gammopathy interference in clinical chemistry assays: mechanisms, detection and prevention
- An Italian program of External Quality Control for chromogranin A (CgA) assay: performance evaluation of CgA determination
- Automated urinalysis: first experiences and a comparison between the Iris iQ200 urine microscopy system, the Sysmex UF-100 flow cytometer and manual microscopic particle counting
- Type B natriuretic peptide stability in frozen plasma
